J.W. Cole Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2M | Buy |
255,629
+46,984
| +23% | +$1.14M | 0.13% | 164 |
|
|
2025
Q1 | $5.29M | Buy |
208,645
+97,092
| +87% | +$2.46M | 0.16% | 135 |
|
|
2024
Q4 | $2.96M | Buy |
111,553
+24,593
| +28% | +$652K | 0.12% | 171 |
|
|
2024
Q3 | $2.52M | Sell |
86,960
-9,888
| -10% | -$286K | 0.11% | 203 |
|
|
2024
Q2 | $2.71M | Sell |
96,848
-46,757
| -33% | -$1.31M | 0.13% | 166 |
|
|
2024
Q1 | $3.98M | Sell |
143,605
-28,574
| -17% | -$793K | 0.2% | 114 |
|
|
2023
Q4 | $4.96M | Buy |
172,179
+34,781
| +25% | +$1M | 0.29% | 81 |
|
|
2023
Q3 | $4.56M | Buy |
137,398
+4,974
| +4% | +$165K | 0.34% | 66 |
|
|
2023
Q2 | $4.86M | Sell |
132,424
-4,692
| -3% | -$172K | 0.35% | 64 |
|
|
2023
Q1 | $5.59M | Buy |
137,116
+19,789
| +17% | +$807K | 0.4% | 53 |
|
|
2022
Q4 | $6.01M | Buy |
117,327
+3,005
| +3% | +$154K | 0.46% | 42 |
|
|
2022
Q3 | $5M | Sell |
114,322
-4,593
| -4% | -$201K | 0.42% | 47 |
|
|
2022
Q2 | $6.24M | Sell |
118,915
-7,613
| -6% | -$399K | 0.5% | 37 |
|
|
2022
Q1 | $6.55M | Buy |
126,528
+256
| +0.2% | +$13.3K | 0.44% | 42 |
|
|
2021
Q4 | $7.46M | Buy |
126,272
+5,711
| +5% | +$337K | 0.49% | 35 |
|
|
2021
Q3 | $5.19M | Buy |
120,561
+2,966
| +3% | +$128K | 0.37% | 46 |
|
|
2021
Q2 | $4.61M | Buy |
117,595
+4,326
| +4% | +$169K | 0.36% | 60 |
|
|
2021
Q1 | $4.1M | Sell |
113,269
-30,451
| -21% | -$1.1M | 0.4% | 53 |
|
|
2020
Q4 | $5.29M | Sell |
143,720
-93,945
| -40% | -$3.46M | 0.55% | 33 |
|
|
2020
Q3 | $8.28M | Buy |
237,665
+126,177
| +113% | +$4.39M | 0.63% | 25 |
|
|
2020
Q2 | $3.46M | Buy |
+111,488
| New | +$3.46M | 0.52% | 47 |
|
|
2020
Q1 | – | Sell |
-99,739
| Closed | -$3.71M | – | 384 |
|
|
2019
Q4 | $3.71M | Buy |
+99,739
| New | +$3.71M | 0.47% | 47 |
|